Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2008-05-15
2009-12-15
Navarro, Mark (Department: 1645)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C536S024300
Reexamination Certificate
active
07632934
ABSTRACT:
Oligonucleotides useful for determining the presence ofTrichomonas vaginalisin a test sample. The oligonucleotides may be incorporated into detection probes, helper probes, capture probes and amplification oligonucleotides, and used in various combinations thereof.
REFERENCES:
patent: 5030557 (1991-07-01), Hogan et al.
patent: 5185439 (1993-02-01), Arnold, Jr. et al.
patent: 5288611 (1994-02-01), Kohne
patent: 5399491 (1995-03-01), Kacian et al.
patent: 5654418 (1997-08-01), Sheiness et al.
patent: 5985563 (1999-11-01), Hyldig-Nielsen et al.
patent: 6130038 (2000-10-01), Becker et al.
patent: 6150517 (2000-11-01), Hogan et al.
patent: 6361945 (2002-03-01), Becker et al.
patent: WO89/04876 (1989-06-01), None
CIPO Office Action, Canadian Patent Application No. 2,525,413, Aug. 22, 2008.
Brown et al., “Evaluation of the Affirm Ambient Temperature Transport System for the Detection and Identification ofTrichomonas vaginalis, Gardnerella vaginalis, andCandidaSpecies from Vaginal Fluid Specimens,” J. Clin. Microbiol., Sep. 2001, 39(9):3197-3199, ASM, USA.
Cotch et al., “Trichomonas vaginalisAssociated With Low Birth Weight and Preterm Delivery,” Sex. Transm. Dis., Jul. 1997, 24(6):353-360, Lippincott, USA.
Cu-Uvin et al., “Prevalence, Incidence, and Persistence or Recurrence of Trichomoniasis among Human Immunodeficiency Virus (HIV)-Positive Women and among HIV-Negative Women at High Risk for HIV Infection,” Clin. Infect. Dis., May 2002, 34:1406-1411, The University of Chicago Press, USA.
Garcia, “Protozoa from Other Body Sites,” Diagnostic Medical Parasitology, 2001, 4thed., pp. 120-131, ASM Press, USA.
Gen-Bank Accession No. U17510, “Trichomonas vaginalis16S-like rRNA gene,” Nov. 30, 1995.
Gunderson et al., “Phylogeny of Trichomonads Inferred from Small-Subunit rRNA Sequences,” J. Euk. Microbiol., Jul.-Aug. 1995, 42(4):411-415, Society of Protozoologists, USA.
Jordan et al., “TaqMan-Based Detection ofTrichomonas vaginalisDNA from Female Genital Specimens,” J. Clin. Microbiol., Nov. 2001, 39(11):3819-3822, ASM, USA.
Kaydos et al., “Development and Validation of a PCR-Based Enzyme-Linked Immunosorbent Assay with Urine for Use in Clinical Research Settings to DetectTrichomonas vaginalisin Women,” J. Clin. Microbiol., Jan. 2002, 40(1):89-95, ASM, USA.
Krieger et al., “Diagnosis of Trichomoniasis—Comparison of Conventional Wet-Mount Examination With Cytologic Studies, Cultures, and Monoclonal Antibody Staining of Direct Specimens,” JAMA, Feb. 1988, 259(8):1223-1227, American Medical Association, USA.
Leber et al., “Intestinal and Urogenital Amebae, Flagellates, and Cillates,” Manual of Clinical Microbiology, 7thed., 1999, pp. 1391-1405, ASM Press, USA.
Mayata et al., “18S Ribosomal DNA-Based PCR for Diagnosis ofTrichomonas vaginalis,” J. Clin. Micrabiol., Jul. 2000, 38(7):2683-2687, ASM, USA.
Niccolai at al., “Incidence and Predictors of Reinfection withTrichomonas vaginalisin HIV-infected Women,” Sex. Transm. Dis., May 2000, 27(5):284-288, Lippincott, USA.
Rein, “Trichomonas vaginalis,” Principles and Practice of Infectious Diseases, 5thed., 2000, pp. 2894-2898, Churchill Livingstone, USA.
Sorvillo et al., “Trichomonas vaginalis, HIV, and African-Americans,” Emerg. Infect. Dis., Nov.-Dec. 2001, 7(6):927-932, CDC, USA.
Sorvillo et al, “Risk Factors for Trichomoniasis Among Women With Human Immunodeficiency Virus (HIV) Infection at a Public Clinic in Los Angeles County, California: Implications for HIV Prevention,” Am. J. Trop. Med. Hyg., 1998, 58(4):495-500, The American Society of Tropical Medicine and Hygiene, USA.
Ter Kuile et al., “Influence of growth conditions on RNA levels in relation to activity of core metabolic enzymes in the parasitic protestsTrypanosoma bruceiandTrichomonas vaginalis,” Microbiol., 1999, 145:755-765, SGM, UK.
Van Der Schee at al., “Improved Diagnosis ofTrichomonas vaginalisInfection by PCR Using Vaginal Swabs and Urine Specimens Compared to Diagnosis by Wet Mount Microscopy, Culture, and Fluorescent Staining,” J. Clin. Microbiol., Dec. 1999, 37(12):4127-4130, ASM, USA.
Wendel et al., “Trichomonas vaginalisPolymerase Chain Reaction Compared with Standard Diagnostic and Therapeutic Protocols for Detection and Treatment of Vaginal Trichomoniasis,” Clin. Infect. Dis., Sep. 2002, 35:576-580, The University of Chicago Press, USA.
PCT Search Report, International Application No. PCT/US04/015742, Aug. 10, 2005.
PCT Written Opinion of the International Searching Authority for International Application No. PCT/US2004/015742, dated Aug. 10, 2005.
Bungo Jennifer J.
Weisburg William G.
Cappellari Charles B.
Gen-Probe Incorporated
Navarro Mark
LandOfFree
Oligonucleotides for amplifying Trichomonas vaginalis... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oligonucleotides for amplifying Trichomonas vaginalis..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oligonucleotides for amplifying Trichomonas vaginalis... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4068197